Syngene International Q4 Results: Profit Up 5.5% At Rs 188.6 Crore, Revenue Falls
2 months ago•Bloomberg Quint
Goldman Sachs Advises Shareholders To Sell And Buy Their Stakes In These Firms - News18
2 months ago•News18
Goldman Sachs Initiates Buy On Syngene, Neuland Labs & A Sell Rating On Laurus Labs | CNBC TV18
2 months ago•CNBC-TV18
Syngene To Neuland And Laurus: Goldman Sachs Initiates Coverage As India Expands Global Pharma Supply
2 months ago•Bloomberg Quint
Syngene Under Pressure As Mgmt Cuts FY24 Revenue Growth Guidance After Reporting Weak Q3 | CNBC TV18
5 months ago•CNBC-TV18
Syngene International Downgraded To ‘Sell’ By UBS On Revenue Growth Headwinds
5 months ago•Bloomberg Quint
Top Stock Picks By Gaurav Bissa Of Incred Equities; Syngene, HDFC Life | Stocks To Buy Today
7 months ago•ET NOW